Literature DB >> 17622420

Synthesis, structure and electroluminescent properties of cyclometalated iridium complexes possessing sterically hindered ligands.

Marappan Velusamy1, K R Justin Thomas, Chih-Hsin Chen, Jiann T Lin, Yuh S Wen, Wan-Ting Hsieh, Chin-Hung Lai, Pi-Tai Chou.   

Abstract

New CN donor ligands incorporating pyridine or benzoimidazole N donors and a sterically hindered cyclometalating aromatic core featuring a polyphenylenephenyl, fluoranthene, or triphenylene segment are prepared and successfully converted into heteroleptic iridium(III) cyclometalated complexes with acetylacetone auxiliary ligands. The X-ray structure of the complex, derived from a ligand containing a fluoranthene fragment, has been solved to unveil the corresponding structure. The results clearly demonstrate that the nature of the sigma-coordinating ligand segment plays a key role in dictating the emission profile and peak position, such that the emission hue has been successfully tuned ranging from green to red. Supplementary support of this viewpoint is also rendered by computational (DFT) approaches. Electroluminescent devices fabricated using a complex as dopant in the PVK matrix were found to exhibit bright greenish yellow emission with promising device characteristics (maximum brightness 26450 cd m(-2) at 30 V and a maximum current efficiency of 40 cd A(-1)).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622420     DOI: 10.1039/b618311e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  8-(Biphenyl-2-yl)-7,9-diphenyl-8H-cyclo-penta-[a]acenaphthylen-8-ol.

Authors:  Peter G Jones; Marc Debeaux; Henning Hopf; Wolfgang Kowalsky; Hans-Hermann Johannes
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-31

2.  Bis-Cyclometalated Indazole and Benzimidazole Chiral-at-Iridium Complexes: Synthesis and Asymmetric Catalysis.

Authors:  Sebastian Brunen; Yvonne Grell; Philipp S Steinlandt; Klaus Harms; Eric Meggers
Journal:  Molecules       Date:  2021-03-24       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.